Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Pharmacopsychiatry
|
November 9, 2000
Increased density of the platelet serotonin transporter in autism
D Marazziti, F Muratori, A Cesari, et al.
Psychiatry Research
|
March 9, 2000
Platelet [3H]paroxetine binding in patients with OCD-related disorders
D Marazziti, L Dell'Osso, S Presta, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 30, 2008
Normalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder
D Marazziti, F Mungai, I Masala, et al.
European Review for Medical and Pharmacological Sciences
|
June 5, 2018
Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections
R Murri, I Mastrorosa, F Taccari, et al.
Psychiatry Research
|
September 11, 2001
Decreased platelet [3H]paroxetine binding sites in suicide attempters
D Marazziti, L Dell'Osso, A Rossi, et al.
Liver
|
July 8, 1999
Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C
G S Baroni, A Pastorelli, A Manzin, et al.
Cell Death & Disease
|
July 30, 2016
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
S Baroni, S Romero-Cordoba, I Plantamura, et al.
BMC Cancer
|
September 6, 2022
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study
F F Pepe, M E Cazzaniga, S Baroni, et al.
Rhinology
|
June 17, 2014
Role of inflammation in non-allergic rhinitis
E de Corso, M Battista, M Pandolfini, et al.
Transplantation Proceedings
|
June 11, 2010
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients
C Comuzzi, D Lorenzin, A Rossetto, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Pharmacopsychiatry
|
November 9, 2000
Increased density of the platelet serotonin transporter in autism
D Marazziti, F Muratori, A Cesari, et al.
Psychiatry Research
|
March 9, 2000
Platelet [3H]paroxetine binding in patients with OCD-related disorders
D Marazziti, L Dell'Osso, S Presta, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 30, 2008
Normalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder
D Marazziti, F Mungai, I Masala, et al.
European Review for Medical and Pharmacological Sciences
|
June 5, 2018
Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections
R Murri, I Mastrorosa, F Taccari, et al.
Psychiatry Research
|
September 11, 2001
Decreased platelet [3H]paroxetine binding sites in suicide attempters
D Marazziti, L Dell'Osso, A Rossi, et al.
Liver
|
July 8, 1999
Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C
G S Baroni, A Pastorelli, A Manzin, et al.
Cell Death & Disease
|
July 30, 2016
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
S Baroni, S Romero-Cordoba, I Plantamura, et al.
BMC Cancer
|
September 6, 2022
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study
F F Pepe, M E Cazzaniga, S Baroni, et al.
Rhinology
|
June 17, 2014
Role of inflammation in non-allergic rhinitis
E de Corso, M Battista, M Pandolfini, et al.
Transplantation Proceedings
|
June 11, 2010
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients
C Comuzzi, D Lorenzin, A Rossetto, et al.
Page
of 8